EcoR1 Capital as of Sept. 30, 2018
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 50 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Fibrogen (FGEN) | 11.0 | $123M | 2.0M | 60.75 | |
| Assembly Biosciences | 9.8 | $109M | 2.9M | 37.14 | |
| Ironwood Pharmaceuticals (IRWD) | 8.6 | $95M | 5.1M | 18.46 | |
| Ascendis Pharma A S (ASND) | 6.9 | $77M | 1.1M | 70.86 | |
| Kura Oncology (KURA) | 6.2 | $68M | 3.9M | 17.50 | |
| Scholar Rock Hldg Corp (SRRK) | 5.5 | $61M | 2.4M | 25.75 | |
| Dicerna Pharmaceuticals | 5.2 | $58M | 3.8M | 15.26 | |
| Spark Therapeutics | 4.1 | $46M | 837k | 54.55 | |
| Macrogenics (MGNX) | 2.9 | $32M | 1.5M | 21.44 | |
| Arcus Biosciences Incorporated (RCUS) | 2.8 | $31M | 2.2M | 13.94 | |
| Kezar Life Sciences (KZR) | 2.5 | $28M | 1.3M | 21.41 | |
| Akcea Therapeutics Inc equities | 2.4 | $26M | 755k | 35.02 | |
| Ultragenyx Pharmaceutical In | 2.2 | $25M | 325k | 76.34 | |
| Gilead Sciences Inc option | 2.0 | $23M | 293k | 77.21 | |
| Crispr Therapeutics (CRSP) | 2.0 | $22M | 500k | 44.35 | |
| Fibrogen | 1.9 | $21M | 350k | 60.75 | |
| Nektar Therapeutics | 1.8 | $20M | 325k | 60.96 | |
| Ultragenyx Pharmaceutical (RARE) | 1.8 | $19M | 254k | 76.34 | |
| Magenta Therapeutics | 1.7 | $19M | 1.5M | 12.01 | |
| Ascendis Pharma A S call | 1.6 | $18M | 257k | 70.86 | |
| Celgene Corp option | 1.6 | $18M | 200k | 89.49 | |
| Unity Biotechnology | 1.4 | $16M | 967k | 16.29 | |
| Surface Oncology | 1.3 | $15M | 1.4M | 10.94 | |
| Rubius Therapeutics | 1.3 | $14M | 592k | 24.00 | |
| Eiger Biopharmaceuticals | 1.1 | $13M | 1.0M | 12.00 | |
| Arbutus Biopharma (ABUS) | 1.1 | $12M | 1.2M | 9.45 | |
| Ironwood Pharmaceuticals Inc cl a | 0.9 | $11M | 568k | 18.46 | |
| Spero Therapeutics (SPRO) | 0.8 | $9.4M | 893k | 10.51 | |
| Immune Design | 0.7 | $7.7M | 2.2M | 3.45 | |
| Zai Lab (ZLAB) | 0.6 | $6.8M | 350k | 19.48 | |
| Aquinox Pharmaceuticals | 0.6 | $6.6M | 2.3M | 2.93 | |
| Elanco Animal Health (ELAN) | 0.6 | $6.6M | 190k | 34.89 | |
| Sangamo Biosciences (SGMO) | 0.5 | $5.8M | 343k | 16.95 | |
| Achillion Pharmaceuticals | 0.5 | $5.8M | 1.6M | 3.68 | |
| Assembly Biosciences Inc call | 0.5 | $5.5M | 148k | 37.14 | |
| Kadmon Hldgs | 0.5 | $4.9M | 1.5M | 3.34 | |
| Mersana Therapeutics (MRSN) | 0.5 | $5.0M | 496k | 10.00 | |
| Ionis Pharmaceuticals (IONS) | 0.3 | $3.7M | 72k | 51.59 | |
| Onconova Therapeutics | 0.3 | $3.7M | 500k | 7.34 | |
| Avrobio Ord (AVRO) | 0.3 | $3.6M | 69k | 51.87 | |
| Jounce Therapeutics Inc call | 0.3 | $3.2M | 497k | 6.50 | |
| Corvus Pharmaceuticals (CRVS) | 0.3 | $3.0M | 351k | 8.58 | |
| Wave Life Sciences (WVE) | 0.2 | $2.2M | 45k | 50.00 | |
| Constellation Pharmceticls I | 0.2 | $1.9M | 280k | 6.73 | |
| Forty Seven | 0.1 | $1.5M | 99k | 14.92 | |
| Chiasma | 0.1 | $1.4M | 380k | 3.60 | |
| Infinity Pharmaceuticals (INFIQ) | 0.1 | $1.3M | 462k | 2.71 | |
| Aptinyx | 0.1 | $1.2M | 41k | 28.95 | |
| Arvinas Ord (ARVN) | 0.1 | $844k | 50k | 16.88 | |
| Erytech Pharma Sa | 0.1 | $590k | 70k | 8.48 |
